We have studied major histocompatibility complex markers in randomly ascertained Caucasian patients with gluten-sensitive enteropathy and their families. The frequencies of extended haplotypes, defined as haplotypes of specific HLA-B, DR, BF, C2, C4A, and C4B allelic combinations, occurring more frequently than expected, were compared on patient chromosomes, on normal chromosomes from the study families, and on chromosomes from normal families. Over half of patient chromosomes consisted almost entirely of two extended haplotypes [HLA-B8, DR3, SCO1j and [HLA-B44, DR7, FC311 which, with nonextended HLA-DR7, accounted for the previously observed HLA markers of this disease: HLA-B8, DR3, and DR7. There was no increase in HLA-DR3 on nonextended haplotypes or in other extended haplotypes with HLA-DR3 or DR7. The distribution of homozygotes and heterozygotes for HLA-DR3 and DR7 was consistent with recessive inheritance of the major histocompatibility complex-linked susceptibility gene for gluten-sensitive enteropathy. On the other hand, by odds ratio analysis and from the sum of DR3 and DR7 homozygotes compared with DR3/ DR7 heterozygotes, there was an increase in heterozygotes and a decrease in homozygotes suggesting the presence of modifying phenomena.
Introduction
Gluten-sensitive enteropathy or celiac disease is a malabsorption syndrome caused by an abnormal sensitivity to wheat and rye gluten. Patients with the disease have severe blunting or absence of villi in the small intestine on biopsy. There is a complete reversion to a normal villus pattern and to normal absorption of food after the removal of gluten from the diet. Although symptoms usually begin in early childhood, the onset may be delayed until adulthood.
Caucasian patients with gluten-sensitive enteropathy have increased frequencies of HLA-A 1, B8, Dw3/DR3, and Dw7/ DR7 and a decreased frequency ofHLA-B7 compared with normal controls (1) (2) (3) (4) . Because the relative risk ofHLA-A I is lower than that of HLA-B8, the latter has been considered primary.
There are four complement genes in the major histocompatibility complex (MHC) between HLA-B and DR. They are inherited as single genetic units called "complotypes" and designated by their BF, C2, C4A, and C4B alleles. Some specific complotype, HLA-B, DR allelic sets occur on random Caucasian Receivedfor publication 21 March 1986 and in revisedform 7 July 1986. chromosomes in significant positive-linkage disequilibrium (their frequency as a haplotype significantly exceeds the frequency predicted by the frequencies ofthe alleles ofwhich they are composed). These are called "extended haplotypes."
Like gluten-sensitive enteropathy, type I diabetes mellitus is an MHC-linked and MHC allele-associated disease. In patients with type I diabetes mellitus, there are increased frequencies of HLA-B8, B18, Bw62, DR3, DR4, and the rare complement alleles BF*FJ and C4B*3 (5) (6) (7) (8) (9) (10) . The increased frequencies of these individual alleles are by and large the result of increased frequencies in a few extended haplotypes which carry them:
[HLA-B8, DR3, SCOl], DR3, FlC30] , and [HLABw62, DR4 , SC33] (11). In diabetes, [HLA-B8, DR3 , SCOl] in patients, in most instances, carries HLA-Al (as does this haplotype in normal individuals) and the allele GLO2 rather than a roughly equal proportion of GLOI and GLO2 as on normal haplotypes.
The present study is of MHC haplotypes in patients with gluten-sensitive enteropathy and their families. Over half of haplotypes from randomly selected, unrelated Caucasian patients with gluten-sensitive enteropathy were found to be accounted for by two extended haplotypes, which in turn account for nearly all the reported positive MHC associations with gluten-sensitive enteropathy.
Methods
Blood samples from 24 random unrelated Caucasian patients with glutensensitive enteropathy and their families were collected into 1 O-ml Vacutainer tubes (Becton, Dickinson & Co., Rutherford, NJ) containing 10.5 mg of potassium EDTA and into a heparinized syringe containing 500-1,000 U of sodium heparin and diluted with an equal volume of RPMI 1640. Lymphocytes were separated by Ficoll-Hypaque, frozen, and stored in vapor-phase liquid nitrogen until thawed for analysis. Plasma was separated by centrifugation and stored at -80°C and thawed just before analysis. No family had more than one affected patient. The diagnosis was established by history, by small intestinal biopsy on gluten-containing diet, and in most instances, by repeat biopsies on and off a gluten-containing diet. The findings of flat villi on gluten and normalization on a gluten-free diet were considered diagnostic.
For the study of C4 polymorphism, plasma samples were incubated with neuraminidase from Clostridium perfringens ( then subjected to electrophoresis in 0.75% agarose gel using a Tris/glycine/ barbital discontinuous buffer system and to immunofixation with antihuman C4 (Atlantic Antibodies, Scarborough, ME) as described earlier (12) . In some cases, samples were also processed as for immunofixation, but were developed with a fourth component of complement (C4) functional overlay consisting of 1% antibody-sensitized sheep erythrocytes in 0.6% isotonic barbital-buffered saline containing Ca2 , Mg2+, and hydrazine-treated normal human serum or C4-deficient guinea pig serum. The presence of null alleles was determined by visual inspection of immunofixation patterns or by crossed immunoelectrophoresis (13).
The nomenclature used for C4 is that described previously (12, 14) . Variants and alleles at each locus have been designated with integers according to the electrophoretic mobility of the desialated proteins at pH 8.8 from cathode to anode. Individual alleles are italicized and designated by locus name in capital letters, an asterisk, and a number or the symbol QO if null (e.g., C4A*2, C4B*1, or C4B*QO). Phenotypes, variants, or proteins are designated with roman capital letters, a space, and the same number or symbol as the corresponding allele.
For BF typing, plasma samples were subjected to agarose gel electrophoresis and immunofixation with anti-human factor B (15) (Atlantic Antibodies). For second component of complement (C2) typing, samples were subjected to isoelectric focusing in thin-layer polyacrylamide gel (16) , using human serum at 1:90 instead of C2-deficient serum in the overlay to develop C2 patterns.
Complotypes are designated by their BF, C2, C4A, and C4B alleles, in that (arbitrary) order (17) . Null or QO alleles are simply 0. Thus, SCOI stands for BF*S, C2*C, C4A*QO, C4B*I. The 48 MHC haplotypes occurring in the 24-patient propositi constituted the gluten-sensitive enteropathy disease chromosomes. A group of 714 MHC haplotypes from random Caucasian patients without MHC-related disease themselves or in close blood relatives was used to construct a population of 357 "normalnormal individuals" assuming the Hardy-Weinberg equilibrium. An additional and separate control population was comprised of the 59 chromosomes from the study families that did not occur in patients (11) . This population of normal chromosomes from the study families was used to assure ethnic matching for the disease chromosomes and is referred to as "family-normal."
HLA-A, B, and C antigens were identified by the standard National Institutes ofHealth lymphocyte microcytotoxicity assay using 140 antisera to define 19 A-locus, 28 B-locus, and 6 C-locus antigens. HLA-DR typing was done with 70 well-characterized alloantisera using the technique of the Oxford (Seventh International Histocompatibility) Workshop (18 The distribution of MHC haplotypes by the HLA-DR allele they carry is shown in Fig. 1 for patient chromosomes, ethnically matched family-normal chromosomes and normal-normal chromosomes. Each bar in Fig. 1 .51, respectively, both P < 0.001 for the comparison with normal-normal haplotypes). That these striking differences were not because ofdifferent ethnicity between the patient and normal haplotypes is seen from the absence of statistically significant differences in HLA-DR and extended haplotype frequencies between family normal and normal-normal chromosomes (Table II) .
As is evident from Table I , the patients were ofa great variety ofethnic backgrounds. These did not appear to differ materially from our general Caucasian population in Boston. the chromosomes of patients with 2 1-hydroxylase deficiency congenital adrenal hyperplasia (24) . The gene for that disorder is known to be in the MHC (25) (26) (27) .
HLA-DR3 and DR4 are increased among patients with type I diabetes, but the ratio of DR3/DR4 heterozygotes is greater than expected from the Hardy-Weinberg equilibrium (assuming pure recessive inheritance) compared with homozygotes for either HLA-DR3 or DR4 (28, 29) . In calculating the relative risks of these different classes of patients, it is important to use the same reference population (non-DR3, non-DR4) in a calculation yielding an odds ratio (28) . An odds ratio for the heterozygote greater than the homozygotes was interpreted by Svejgaard and Ryder as being consistent with "overdominant" inheritance, although other explanations including multiple gene interactions are possible. Since gluten-sensitive enteropathy also has two (30, 31) . Although families with more than one affected sib with gluten-sensitive enteropathy are rare, they tend to be HLA-identical, in keeping with largely recessive inheritance (32, 33) . In type 1 diabetes mellitus, the increase in HLA-DR3 is the result solely ofan increase in DR3-bearing extended haplotypes, whereas the increase in HLA-DR4 is associated with an increase both in specific DR4-bearing extended haplotypes and an increase in DR4 haplotypes that are not recognizably extended. The situation in gluten-sensitive enteropathy is closely analogous with the increase in HLA-DR3 consisting only of one extended haplotype, whereas the increase in HLA-DR7 is in both one extended haplotype and in nonextended DR7. In both diseases, it may be that the nonextended haplotypes associated with HLA-DR4 and DR7, respectively, contain fragments of extended haplotypes. 1] in gluten-sensitive enteropathy, is greatly influenced by its frequency in the normal population. In general, the rarer the marker in the control population, the greater its tendency to overaffect the relative risk. If one uses relative risks too literally, one could conclude that since HLA-B8 has a higher relative risk than either HLA-A I or HLA-DR3, the gluten-sensitive enteropathy susceptibility gene must be the same as HLA-B8 or close to HLA-B. This contradicts the conclusion that HLA-DR7 or HLA-DR is primary as judged from the fact that HLA-DR7 has a higher relative risk than either HLA-B44 or FC3 1. It is certainly not consistent with HLA-A29 being primary because it has the highest relative risk on the haplotype HLA-A29, B44, DR7, FC3 1. The fact that the majority of patient [HLA-B8, DR3, SCO ] do not carry HLA-A1 accounts mainly for the lower relative risk ofHLA-A1 compared with that ofHLA-B8 or DR3 observed in our study. In addition, there certainly is some population heterogeneity of allele frequencies in published studies, as judged from HLA studies of Caucasian patients in different regions (1) (2) (3) (4) . Our HLA-A 1 relative risk of 1.7 is somewhat lower than that reported in a U.S. population at 3.64 (35) 
